Calendar Companies Compare Analytics Learn Watchlist

Search CatalystAlert

Search for companies, drugs, and catalysts

Loading market movers...

Free biotech catalyst calendar tracking FDA decisions, clinical trial results, and PDUFA dates for biotech stocks.

Quick Links

Catalyst Calendar
Search Companies
Biotech Glossary
Therapeutic Areas

Legal

About
Privacy
Terms

Data Sources

ClinicalTrials.gov
SEC EDGAR
FDA

© 2025 CatalystAlert. All rights reserved.

Not financial advice. Data may be delayed or incomplete.

Rosnilimab - Phase 2 | ANAB Pipeline | CatalystAlert

Rosnilimab

Phase 2

AnaptysBio, Inc. (ANAB)

17%

Phase 2

Development Phase

1

Upcoming Catalysts

0

Historical Events

0

Regulatory Approvals

Upcoming Catalysts

Jan 2026~

ANABPhase 2Phase 2

Rosnilimab Phase 2 Results Expected

Rosnilimab • Rheumatoid Arthritis

Drug Information

Target Indication

Rheumatoid Arthritis

Clinical Trial

Last updated: 12/4/2025

Developer

ANAB

AnaptysBio, Inc.

Biotechnology•North America•NASDAQ